ChatGPT

https://chatgpt.com/share/6ac1cc42-bb7c-83ec-af05-e4a7e5041a94

Yes. But the system we should build is **not an “anti-aging chatbot.”** It should be an autonomous scientific discovery system whose job is to discover interventions that restore damaged biological systems and then prove that they work.

The important conceptual shift is:

> **Do not build an AI that knows everything humans know. Build an AI that can discover things humans do not know.**

That requires a closed experimental loop.

1. 1. The architecture I would build

```text

┌──────────────────────────┐

│ HUMAN OBJECTIVE │

│ │

│ "Restore youthful │

│ biological function" │

└────────────┬─────────────┘

│

▼

┌─────────────────────────────────┐

│ BIOLOGICAL WORLD MODEL │

│ │

│ genome │

│ epigenome │

│ transcriptome │

│ proteome │

│ metabolome │

│ cell state │

│ tissue state │

│ organ state │

│ immune system │

│ microbiome │

│ clinical phenotype │

└───────────────┬─────────────────┘

│

┌──────────────────┼──────────────────┐

▼ ▼ ▼

┌────────────────┐ ┌────────────────┐ ┌────────────────┐

│ SCIENTIST AI │ │ CAUSAL ENGINE │ │ SIMULATION AI │

│ │ │ │ │ │

│ hypotheses │ │ cause/effect │ │ virtual cells │

│ literature │ │ networks │ │ tissues │

│ reasoning │ │ interventions │ │ organs │

│ contradictions │ │ counterfactual │ │ drug effects │

└───────┬────────┘ └───────┬────────┘ └───────┬────────┘

└──────────────────┼──────────────────┘

▼

┌────────────────────────────┐

│ DISCOVERY / DESIGN AI │

│ │

│ drugs │

│ proteins │

│ antibodies │

│ gene-regulation strategies │

│ cell therapies │

│ combinations │

└──────────────┬─────────────┘

▼

┌────────────────────────────┐

│ EXPERIMENT PLANNER / │

│ ACTIVE LEARNING ENGINE │

│ │

│ "Which experiment gives us │

│ the most information?" │

└──────────────┬─────────────┘

▼

┌────────────────────────────┐

│ AUTONOMOUS LABORATORY │

│ │

│ robotic experiments │

│ cell systems │

│ organoids │

│ molecular assays │

│ imaging │

│ sequencing │

└──────────────┬─────────────┘

│

▼

┌────────────────────────────┐

│ OBSERVATION ENGINE │

│ │

│ What actually happened? │

│ Did prediction fail? │

│ Did intervention work? │

│ What unexpected effect? │

└──────────────┬─────────────┘

│

└──────► WORLD MODEL

↑

│

ITERATE

```

That last arrow is the most important part.

• AI → experiment → observation → learning → new hypothesis → experiment.**

That is how it gets beyond the existing human literature.

Current systems are already moving toward pieces of this architecture. Google has demonstrated a multi-agent “AI co-scientist” for hypothesis generation, while recent work on self-driving laboratories describes systems in which AI proposes, executes and interprets experiments. ([Google Research][1])

But we would go considerably further.

---

1. 2. The central intelligence should be a biological world model

A conventional LLM primarily models language.

Our AI needs to model **biology**.

It needs to represent something resembling:

```text

DNA

↓

RNA

↓

proteins

↓

metabolic pathways

↓

cell state

↓

cell-cell interactions

↓

tissue

↓

organ

↓

whole organism

↓

clinical phenotype

```

And it needs to represent time:

```text

young → middle age → old → disease

```

and interventions:

```text

state(t)

+

intervention

↓

state(t+1)

```

The system's fundamental question becomes:

> **"What intervention changes this biological system from its current state to a healthier state?"**

That is fundamentally different from asking an LLM for medical advice.

---

1. 3. Feed it vastly more than scientific papers

Papers are only one layer.

I would build a gigantic multimodal biological database containing:

1. Molecular data

Genomics

Epigenomics

Transcriptomics

Proteomics

Metabolomics

Lipidomics

Glycomics

Microbiome data

1. Cellular data

Single-cell RNA

Single-cell epigenetics

Single-cell proteomics

Spatial transcriptomics

Cell morphology

Cell lineage

Cell-state transitions

Single-cell foundation models are already being developed for this purpose, although evaluations show that simply making these models enormous does not automatically produce deep biological understanding. ([Nature][2])

1. Experimental data

This is especially important.

We need:

```text

gene perturbation → outcome

protein perturbation → outcome

drug → outcome

drug combination → outcome

environment → outcome

cell-state manipulation → outcome

```

including **failed experiments**.

A failed experiment is extremely valuable because it constrains the biological model.

1. Human longitudinal data

The AI needs to understand how an individual changes over decades:

```text

age

↓

blood markers

↓

genome

↓

epigenome

↓

proteome

↓

imaging

↓

organ function

↓

disease

↓

death

```

This is where biological aging clocks become useful, although they must not be treated as the ultimate definition of aging. Researchers are already developing multi-organ aging models incorporating clinical, imaging and proteomic information. ([Nature][3])

---

1. 4. Give the AI multiple scientific personalities

I would **not** use one model to do everything.

Instead:

1. Scientist 1 — The Explorer

Generates thousands of possible explanations.

1. Scientist 2 — The Mechanistic Biologist

Asks:

> Does this hypothesis actually make biological sense?

1. Scientist 3 — The Causal Scientist

Asks:

> Is this relationship causal, or merely correlated?

1. Scientist 4 — The Molecular Designer

Designs candidate molecules, proteins or other interventions.

Modern protein-design systems demonstrate why this component is powerful. AlphaProteo, for example, has demonstrated AI-designed protein binders with experimentally tested binding activity. ([Google DeepMind][4])

1. Scientist 5 — The Experimentalist

Designs the experiment needed to distinguish competing hypotheses.

1. Scientist 6 — The Statistician

Tries to destroy the conclusion.

1. Scientist 7 — The Skeptic

Its explicit purpose:

> **"Prove that we're wrong."**

This is critical.

1. Scientist 8 — The Clinician

Asks:

> Does this mechanism actually matter to human disease?

1. Scientist 9 — The Longevity Scientist

Looks across the entire aging system rather than optimizing one disease.

1. Scientist 10 — The Integrator

Combines all of them into a single scientific conclusion.

This is similar in spirit to the multi-agent direction already being explored by AI co-scientist systems, but our system would add much deeper biological models and experimental feedback. ([Google Research][5])

---

1. 5. The AI needs a "knowledge boundary"

This is one of the most important pieces.

The AI should maintain a graph like:

```text

KNOWN

│

┌────────────┼─────────────┐

│ │ │

confirmed probable disputed

│ │ │

└────────────┼─────────────┘

│

UNKNOWN

│

UNKNOWN-UNKNOWN

```

The last category is particularly interesting.

For example:

Human researchers might know:

```text

A → B

B → C

```

The AI might hypothesize:

```text

A → X → Y → C

```

where X and Y have never previously been identified as relevant.

But the AI must then **test it**.

This is how we move from:

> knowledge retrieval

to:

> knowledge generation.

---

1. 6. Don't reward novelty. Reward experimentally confirmed prediction

This is another crucial design decision.

Otherwise the AI will produce spectacular nonsense.

The reward function should look something like:

```text

Scientific value =

mechanistic plausibility

+ predictive accuracy

+ causal effect

+ reproducibility

+ therapeutic benefit

+ safety

+ generalization

+ novelty

```

Notice that **novelty comes last**.

A completely original hypothesis that is wrong is worthless.

A completely original hypothesis that predicts something experimentally unknown—and then survives rigorous testing—is enormously valuable.

---

1. 7. The experiment-selection engine is the real superpower

Suppose the AI has 10,000 hypotheses.

It does **not** simply test the 10,000 most promising ones.

It asks:

> **Which experiment will teach us the most?**

For example:

```text

Hypothesis A

Hypothesis B

Hypothesis C

Hypothesis D

```

The AI calculates that experiment X will distinguish A/B from C/D.

Therefore:

```text

Experiment X

↓

huge reduction in uncertainty

```

This is **active learning / Bayesian experimental design**.

Instead of researchers deciding:

> "What experiment should we run next?"

the AI continually decides:

> **"What is the most informative experiment we can possibly afford to run next?"**

This is a major reason autonomous laboratories are important. The 2026 review of self-driving laboratories explicitly identifies scalable experimentation, portability across laboratories, complete experimental provenance and AI reasoning under uncertainty as central requirements for the next generation. ([Nature][6])

---

1. 8. Build a virtual human, but don't trust it

We should create progressively more sophisticated biological simulation.

Something like:

```text

Level 1

molecule

Level 2

protein interaction

Level 3

gene regulatory network

Level 4

cell

Level 5

cell population

Level 6

tissue

Level 7

organ

Level 8

whole-body model

```

Eventually:

```text

DIGITAL HUMAN

```

But this model is **not regarded as truth**.

It's a hypothesis generator.

The system continuously compares:

```text

predicted biology

vs.

actual experiment

```

and updates the model.

Digital twins are already being explored for disease modelling and treatment-response simulation, particularly by integrating molecular and clinical information. ([Nature][7])

---

1. 9. Aging should be treated as a repair problem

I wouldn't tell the AI:

> "Find a drug that makes people live longer."

That's too vague.

I'd define the objective as:

> **Restore and maintain youthful biological function while preventing cancer, toxicity and loss of organismal stability.**

That decomposes aging into repair problems.

For example:

```text

DNA damage

↓

epigenetic drift

↓

loss of proteostasis

↓

mitochondrial dysfunction

↓

cellular senescence

↓

stem-cell dysfunction

↓

immune dysfunction

↓

extracellular-matrix deterioration

↓

chronic inflammatory signalling

↓

organ dysfunction

```

The AI then asks:

> Which of these are causes?

> Which are consequences?

> Which are feedback loops?

> Which can be reversed?

> Which combinations produce rejuvenation?

> Which interventions merely make an aging clock look younger without restoring function?

That distinction is extremely important because aging biology is still not sufficiently understood to claim that any single intervention cures aging. NIH describes research as pursuing interventions that may slow or reverse molecular aging, while emphasizing that the field is still investigating the underlying mechanisms. ([National Institute on Aging][8])

---

1. 10. It should search for combinations, not just magic bullets

A major possibility is that aging cannot be "cured" by one molecule.

Imagine:

```text

Intervention A

repairs epigenetic state

+

Intervention B

removes dysfunctional cells

+

Intervention C

restores mitochondrial function

+

Intervention D

restores extracellular environment

+

Intervention E

rebuilds stem-cell populations

```

The AI can explore the enormous combination space.

Humans are extremely poor at searching combinatorial spaces of this magnitude.

The AI could discover:

```text

A alone = +5%

B alone = +8%

C alone = +3%

A+B = +18%

A+C = +9%

B+C = +12%

A+B+C = +47%

```

while also identifying dangerous combinations.

---

1. 11. The experimental hierarchy

We don't immediately jump from AI prediction to human treatment.

The loop should be:

```text

COMPUTATIONAL

↓

molecular simulation

↓

biochemical validation

↓

human-cell systems

↓

3D organoids

↓

tissue models

↓

animal validation

↓

human clinical research

↓

long-term monitoring

```

And crucially, the system should be learning at every stage.

---

1. 12. The clinical AI should become a second system

Once the discovery engine finds an intervention, another AI asks:

```text

Who should receive it?

At what biological age?

At what disease stage?

What biomarkers identify responders?

What dose?

What combination?

What sequence?

What toxicity?

What organs are vulnerable?

```

This leads toward personalized medicine rather than:

> one drug for everybody.

---

1. 13. The architecture should therefore be hierarchical

I'd build approximately this:

```text

┌─────────────────────┐

│ GENERAL REASONER │

└──────────┬──────────┘

│

┌───────────────────┼──────────────────┐

│ │ │

▼ ▼ ▼

BIOLOGY FM CAUSAL MODEL SCIENCE MEMORY

│ │ │

└───────────────────┼──────────────────┘

▼

HYPOTHESIS ENGINE

│

▼

SIMULATION ENGINE

│

▼

EXPERIMENT OPTIMIZER

│

▼

ROBOTIC LAB SYSTEM

│

▼

EXPERIMENTAL RESULTS

│

▼

EVIDENCE ENGINE

│

┌────────┴────────┐

▼ ▼

MODEL UPDATE HUMAN REVIEW

│

└─────────► repeat

```

---

1. 14. A critical component: scientific memory

The AI needs a persistent memory far beyond a conventional vector database.

I'd maintain:

1. Literature graph

```text

paper

author

experiment

result

claim

gene

protein

pathway

disease

intervention

```

1. Experimental graph

```text

experiment

→ conditions

→ intervention

→ measurement

→ result

→ replicate

→ laboratory

```

1. Causal graph

```text

cause

↓

mechanism

↓

phenotype

```

1. Uncertainty graph

```text

claim

confidence = 0.71

evidence = 37 experiments

contradictions = 4

```

1. Provenance

Every conclusion needs to answer:

> Where did this belief come from?

The 2026 self-driving-lab literature emphasizes precisely this kind of provenance-complete experimental record as a prerequisite for scalable scientific autonomy. ([Nature][6])

---

1. 15. How I would actually build version 1

I would **not** begin by training a gigantic foundation model.

That would consume enormous resources before we know whether the architecture works.

I'd build an MVP around existing models.

1. Layer 1 — Scientific data

```text

PostgreSQL

+

object storage

+

Parquet

+

graph database

+

vector search

```

1. Layer 2 — Knowledge ingestion

Build pipelines that ingest:

```text

scientific literature

clinical datasets

genomic datasets

proteomic datasets

single-cell datasets

drug databases

protein structures

experimental datasets

```

1. Layer 3 — Reasoning

Use several strong reasoning models rather than one.

The models communicate through structured scientific objects:

```json

{

"hypothesis": "...",

"mechanism": "...",

"prediction": "...",

"uncertainty": 0.31,

"experiment_needed": "...",

"expected_result": "...",

"falsifier": "..."

}

```

That is much better than agents merely exchanging prose.

1. Layer 4 — Biological models

Add dedicated models for:

```text

protein structure

molecular interaction

gene regulation

single-cell biology

omics

drug-response prediction

causal inference

```

AlphaFold 3 demonstrates how far specialized biomolecular models have already progressed in predicting complexes involving proteins, nucleic acids, ligands and ions. ([Nature][9])

1. Layer 5 — Discovery engine

Generate:

```text

new targets

new mechanisms

new molecules

new proteins

new combinations

new cellular interventions

```

1. Layer 6 — Experimental interface

Initially, humans operate the experiments.

Then gradually automate the safest, most standardized experiments.

Eventually:

```text

AI selects experiment

↓

robot prepares it

↓

robot measures it

↓

AI interprets it

↓

AI chooses next experiment

```

---

1. 16. Then give it a real laboratory

This is where the system becomes fundamentally different from ChatGPT.

Imagine:

```text

AI

│

"Test hypothesis 742"

│

▼

experiment planner

│

▼

robot lab

┌──────────┼─────────┐

│ │ │

culture assay imaging

│ │ │

└──────────┼─────────┘

▼

sequencing /

proteomics /

microscopy

│

▼

raw data

│

▼

AI analysis

│

▼

hypothesis updated

```

The AI doesn't need to wait for humans to write another paper.

• The laboratory becomes its sensory system.**

---

1. 17. The most important training data will eventually be generated by the AI itself

Initially:

```text

human science

↓

AI

```

Then:

```text

human science

+

AI experiments

↓

AI

```

Eventually:

```text

human discoveries

+

AI discoveries

+

AI failures

+

AI experiments

↓

much better biological model

```

This creates a positive feedback loop:

```text

better model

↓

better hypotheses

↓

better experiments

↓

better data

↓

better model

```

That is the route toward something genuinely beyond human scientific capability.

---

1. 18. We should optimize for "biological restoration," not lifespan

This is perhaps the most important philosophical/technical decision.

A model could discover something that makes mice live longer while making them frail.

That is not the objective.

The objective should be something closer to:

```text

↑ cardiovascular function

↑ cognitive function

↑ muscle function

↑ immune competence

↑ regeneration

↑ metabolic function

↓ cancer

↓ fibrosis

↓ inflammation

↓ senescent-cell burden

↓ molecular damage

↓ organ dysfunction

```

while maintaining:

```text

genomic stability

neurological identity

normal development

fertility where desired

immune balance

absence of uncontrolled proliferation

```

In other words:

> **Make the organism functionally young, not merely alive for longer.**

This matters because many proposed gerotherapeutic approaches remain scientifically uncertain in humans. For example, recent reviews note promising senolytic biology but insufficient evidence that current approaches produce clinical efficacy, while emphasizing the need for more selective strategies. ([Nature][10])

---

1. 19. The AI needs an anti-hallucination architecture

Normal LLM behavior is dangerous for scientific discovery.

It must not say:

> "This pathway probably works."

Instead every claim should carry:

```text

Evidence:

experimental

observational

simulation

literature-derived

AI-derived

Confidence:

0.00–1.00

Known contradictions:

...

Testable prediction:

...

Falsification experiment:

...

```

An AI scientist should be **obsessed with being falsified**.

---

1. 20. Human scientists shouldn't be removed

Interestingly, I would keep humans at the top of the hierarchy.

Not because humans will necessarily be smarter.

Because the system needs humans for:

```text

goals

ethics

clinical decisions

risk tolerance

experimental authorization

safety

interpretation of genuinely unprecedented results

```

The AI does the enormous search.

Humans provide the civilization-level objectives and constraints.

---

1. 21. The ultimate version

The end-state looks something like this:

```text

SCIENTIFIC SUPERINTELLIGENCE

│

┌───────────────────┼────────────────────┐

│ │ │

KNOWLEDGE WORLD MODEL DISCOVERY

│ │ │

│ │ │

billions of virtual cells new biology

observations tissues new mechanisms

new drugs

new therapies

│ │ │

└───────────────────┼────────────────────┘

│

EXPERIMENTAL AI

│

autonomous lab

│

▼

REAL BIOLOGY

│

▼

NEW KNOWLEDGE

│

└───────────────► AI

```

And then it keeps running.

---

1. 22. The first actual mission

I would **not** begin with:

> "Cure aging."

That's too large to evaluate.

The first mission should be something measurable such as:

> **Discover a previously unknown intervention that restores an aged human cell to a demonstrably younger functional state, without causing malignant transformation or loss of cell identity.**

Then define success experimentally.

For example:

```text

INPUT

aged human cells

AI

↓

find mechanism

↓

design intervention

OUTPUT

cells with restored:

molecular state

metabolic function

stress resistance

appropriate gene regulation

normal cellular identity

```

And require the result to survive **independent validation**.

Once the AI can repeatedly discover things humans did not know and experimentally confirm them, expand:

```text

cell

↓

tissue

↓

organ

↓

animal

↓

human disease

↓

multi-organ aging

```

That gives us a ladder rather than a moonshot with no measurable progress.

---

1. The central idea

The breakthrough will probably **not** come from having a larger language model.

It will come from combining:

• reasoning + biological foundation models + causal inference + simulation + molecular design + autonomous experimentation + persistent scientific memory.**

The existing research already points toward each of those components separately: multimodal biological foundation models are being proposed to integrate genomics, transcriptomics, epigenomics, proteomics, metabolomics and spatial profiling; AI co-scientist systems are generating research hypotheses; and self-driving laboratories are beginning to close the loop between AI and physical experimentation. ([Nature][11])

• Our opportunity is to combine them into one system whose explicit objective is biological repair and whose source of new knowledge is experimentation.**

That is the architecture I would pursue for an actual **AI Longevity Scientist** rather than an AI medical assistant.

[1]: https://research.google/blog/accelerating-scientific-breakthroughs-with-an-ai-co-scientist/?hl=tr&utm_source=chatgpt.com "Accelerating scientific breakthroughs with an AI co-scientist"

[2]: https://www.nature.com/articles/s12276-025-01547-5?utm_source=chatgpt.com "Single-cell foundation models: bringing artificial intelligence into cell biology | Experimental & Molecular Medicine"

[3]: https://www.nature.com/articles/s43587-025-00928-9?utm_source=chatgpt.com "Refining the generation, interpretation and application of multi-organ, multi-omics biological aging clocks | Nature Aging"

[4]: https://deepmind.google/blog/alphaproteo-generates-novel-proteins-for-biology-and-health-research/?utm_source=chatgpt.com "AlphaProteo generates novel proteins for biology and health research — Google DeepMind"

[5]: https://research.google/blog/google-research-2025-bolder-breakthroughs-bigger-impact/?utm_source=chatgpt.com "Google Research 2025: Bolder breakthroughs, bigger impact"

[6]: https://www.nature.com/articles/s41570-026-00847-2?utm_source=chatgpt.com "The past, present and future of self-driving laboratories | Nature Reviews Chemistry"

[7]: https://www.nature.com/articles/s41568-025-00850-7?utm_source=chatgpt.com "Application of digital twins for personalized oncology | Nature Reviews Cancer"

[8]: https://www.nia.nih.gov/news/research-context-can-we-slow-aging?utm_source=chatgpt.com "Research in Context: Can we slow aging? | National Institute on Aging"

[9]: https://www.nature.com/articles/s41586-024-07487-w?utm_source=chatgpt.com "Accurate structure prediction of biomolecular interactions with AlphaFold 3 | Nature"

[10]: https://www.nature.com/articles/s43587-025-00964-5?utm_source=chatgpt.com "Towards a personalized approach in senolytic trials | Nature Aging"

[11]: https://www.nature.com/articles/s41586-025-08710-y?utm_source=chatgpt.com "Towards multimodal foundation models in molecular cell biology | Nature"

Claude

Nobody knows the design yet, but we can say what the problem demands. The hard part isn't just building a smart model. It's building a system that can learn things humans don't know, in a field where feedback is slow and expensive.

1. Why "just train a big model" won't work

Language models learn from human-written text, so they mostly recombine what humans already know. Systems that exceeded human knowledge, like AlphaGo and AlphaFold, did it where there was a **reliable, fast signal of correctness**: win or lose, or a measured protein structure. Aging has no such signal. A lifespan experiment in mice takes years, and in humans, decades. So the central design question is how to create a fast, trustworthy feedback loop for biology.

1. A plausible architecture

• 1. Biological foundation models.** Models trained on genomes, single-cell data, proteomics, epigenetics, imaging, and clinical records, aiming at a "virtual cell" that predicts how a cell responds to a gene edit, drug, or stress. Today's versions are crude, but this is the direction.

• 2. A reasoning and hypothesis layer.** A language-model-based agent that reads the literature, finds contradictions and gaps, proposes mechanisms, and designs experiments to distinguish between them.

• 3. Closed-loop automated labs.** This is the key piece for exceeding human knowledge. The AI designs experiments, robots run them (cell cultures, organoids, high-throughput screens), the results come back automatically, and the models update. This lets the AI generate new data nobody has collected, rather than just reading old data.

• 4. Measurement of aging itself.** We need validated biomarkers (epigenetic clocks, multi-omic signatures, functional tests) that predict healthspan, so the AI has something to optimize that stands in for decades of waiting. Poor biomarkers are probably the biggest scientific risk: the AI could optimize a number that doesn't reflect real aging.

• 5. Staged validation.** Cells and organoids, then short-lived animals (worms, flies, killifish, mice), then human trials. Each stage feeds results back into the models, especially failures, since translation from animal to human is where most therapies die.

• 6. Human oversight and safety.** Experts review proposed interventions, especially anything involving gene editing or reprogramming, and regulators need to be involved early.

1. How you'd actually build it

1. Start narrow: pick one tractable slice (say, cellular senescence or partial epigenetic reprogramming) rather than "cure aging."

2. Build the data engine first. Generating large, consistent, high-quality datasets (perturbation screens, longitudinal human multi-omics) matters more than model architecture.

3. Build or partner for lab automation, so the AI can run experiments.

4. Develop and validate aging biomarkers against real outcomes in large cohorts like biobanks.

5. Scale the loop: more experiments, better models, better experiment selection.

6. Move promising candidates into clinical trials, which will be the slowest and costliest step regardless of how smart the AI is.

1. Honest caveats

- **Aging is not one disease.** It's many interacting processes, so there may never be a single "cure," more likely a stack of interventions that extend healthy years.

- **Intelligence isn't the only bottleneck.** Biology's constraints are physical: experiments take time, humans take decades, and trials need safety evidence. A superintelligent AI would speed up discovery but couldn't skip those steps.

- **Regulation:** aging isn't currently recognized as an indication by the FDA, which shapes how trials can be designed.

- **Risk:** an AI that designs powerful biological interventions is also dual-use, so access control and biosecurity need to be designed in from the start.

If you tell me whether you're thinking about this as a startup, a research project, or a conceptual exercise, I can go deeper on the parts that matter most for you.